* Swipe to the right and check.
PIPELINE | TARGET | Discovery | Preclinical | IND Enabling | Clinical |
---|---|---|---|---|---|
MG-PE3 | Alzheimer’s disease | ||||
MG-Sh19 | |||||
MG-G101 | Glioblastoma | ||||
MG-T101 | Immuno-Oncology | ||||
MG-N101 |
We hold innovative biomimetic nanoparticle platform technology that can deliver drugs effectively. We have Alzheimer’s new drug pipelines that enables amyloid beta clearance and ameliorates neuroinflammation mediated by microglia.
Our MEPS-X platform also enables in-depth mechanism studies and more efficient evaluation of our new drug pipelines.